Analyst Rick Wise works at STIFEL and is focused on the Healthcare sector with 365 price targets and ratings documented since 2014 spanning on 26 stocks. Analyst's average stock valuation to be materialised ratio is 63.95% with an average time for price targets to be met of 168.5 days.
Most recent stock forecast was given on TMCI, Treace Medical Concepts Inc at 21-Sep-2022.
Rick Wise best performing recommendations are on ATRC (ATRICURE, INC).
The best stock recommendation documented was for BSX (BOSTON SCIENTIFIC CORPORATION) at 3/24/2020. The price target of $30 was fulfilled within 2 days with a profit of $1.78 (6.31%) receiving and performance score of 31.54.
Average potential price target upside